—
Pharmaceutical companies with annual revenue in 2016 of between $1 billion and $10 billion are considered to be mid-size companies in the report. The mid-size pharma market is growing rapidly. Most of these companies are focusing heavily on developing a portfolio of generic products covering a variety of therapy areas and geographies. They have been competing with large pharma by developing generic products of high value innovative biologics after their patent expiry.Report Source: https://www.themarketreports.com/report/the-mid-size-pharmaceutical-market-market-assessment-growth-forecasts-and-strategic-consolidations-for-key-players
Scope
• How can the mid-sized pharma segment be defined in general, and what is its role in the industry?
• Which mid-size pharma companies are on the leaders in terms of revenue, R&D expenditure, number of R&D products, marketed products and number of employees in 2016?
• What is the revenue forecast for the key mid-size companies in 2023?
• What are the key marketed products of the top mid-size pharma companies? What were the global sales figures in 2016 and what are the forecasts for 2023 for these products?
• Which therapy areas are the key mid-size companies are focusing on? What are the global sales forecasts of late-stage pipeline products that are set to enter the market during the forecast period?
• What was the year-on-year revenue growth and year-on-year R&D expenditure of key mid-size pharma companies between 2014 and 2016?
• What are the key strategies followed by mid-size pharma companies to improve their revenue and push towards joining the large pharma
Purchase this report at: https://www.themarketreports.com/report/buy-now/1184135
Reasons To Buy
• Interpret the key players in the mid-size pharma segment through the analysis of companies, particularly based on R&D investments, year-on-year revenue and R&D expenditure, and pipeline and marketed products.
• Gain insights on how mid-size pharma companies have explored new technologies to shape their current portfolios and R&D pipelines.
• Understand the detailed profiling of top mid-size pharma companies based on their revenue in 2016. The profiling of the companies includes top-selling marketed products, major late-stage pipeline products expected to enter into the market in the near future and their forecasts, and key deals analysis.
• Recognize the various challenges faced by mid-size pharma companies.
• Understand the major growth strategies followed by mid-size pharma companies in recent years.
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1184135
Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315
Website: https://www.themarketreports.com/report/the-mid-size-pharmaceutical-market-market-assessment-growth-forecasts-and-strategic-consolidations-for-key-players
Release ID: 360076
Google
RSS